Pacific Biosciences of California, Inc.

NASDAQ:PACB

Medical - Devices

Healthcare
$1.83 +3.17%

+$0.04 today

Market cap
$571.39M
Beta
2.32
P/E (TTM)
-3.3
EPS (TTM)
-$0.42
52W Low $1.09High $2.73

Volume 15.30M

Average 6.06M

PACB Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Pacific Biosciences of California, Inc.NASDAQ: PACB

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses growth accelerates

Q1 FY2026 other income / expenses of $29.83M rose 1066.6% year over year, ahead of the -78.7% change in trailing-twelve-month other income / expenses. Sequentially, it rose 2801.7% from the prior quarter.

Context

  • Other income / expenses amounted to 7.2% of revenue in FY2025, down 99.8 pp from a year earlier.
  • Other income / expenses increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +1066.6% holds above the trailing-twelve-month pace of -78.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$29.83M+2801.7% QoQ
Last fiscal yearDec 2025
$11.5M-93.0% YoY
LTMMar 2026
$35.01M-78.7% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1066.6%——
1 year-93.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
11.5M USD
Year-over-year change
-93.0%

Other Income / Expenses vs competitors

How PACB compares with its peers on the latest reported figures

  • PACB's LTM Mar 2026 other income / expenses of $35.01M is the 2nd highest of the 3 companies compared; the peer median is $32.7M.
  • Its year-over-year change of -78.7% is the 2nd highest of 3, against a peer median of -61.6%.
  • Other income / expenses amounts to 21.9% of revenue for PACB, versus a peer median of 205.9%.
PACB Competitors Peer median
Other Income / Expenses for PACB and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ILMNIllumina, Inc.LTM Jun 2026$73M +55.3%—1.6%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$35.01M -78.7%—21.9%
QSIQuantum-Si incorporatedLTM Mar 2026-$7.6M -178.5%—410.1%
Peer median (excluding PACB) $32.7M-61.6%—205.9%

Competitors are the stored peer set for PACB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue130.51M128.3M200.52M154.01M160.01M
Cost of Revenue71.65M79.27M147.74M116.73M109.33M
Gross Profit58.86M49.04M52.78M37.28M50.67M
Gross Margin45.1%38.2%26.3%24.2%31.7%
Research & Development112.9M193M187.17M134.92M97.31M
Selling, General & Admin124.12M160.85M169.82M175.02M141.49M
Operating Expenses269.3M356.23M387.25M511.6M608.24M
Depreciation & Amortization11.59M17.32M32.69M53.35M504.91M
EBITDA(250.76M)(282.24M)(271.13M)(242.77M)(34.2M)
EBITDA Margin-192.1%-220.0%-135.2%-157.6%-21.4%
Operating Income(210.44M)(307.2M)(334.47M)(474.31M)(557.56M)
Operating Margin-161.2%-239.4%-166.8%-308.0%-348.5%
Interest Income00000
Interest Expense12.53M14.69M14.34M13.41M6.95M
Other Income / Expenses(64.44M)(7.05M)16.31M164.78M11.5M
Income Before Tax(274.87M)(314.25M)(318.16M)(309.54M)(546.06M)
Pre-Tax Margin-210.6%-244.9%-158.7%-201.0%-341.3%
Income Tax Expense(93.65M)0(11.42M)316K318K
Net Income(181.22M)(314.25M)(306.74M)(309.85M)(546.38M)
Net Margin-138.9%-244.9%-153.0%-201.2%-341.5%
EPS (Basic)(0.89)(1.40)(1.21)(1.13)(1.82)
EPS (Diluted)(0.89)(1.40)(1.21)(1.07)(1.82)
Weighted Avg Shares203.62M224.55M253.63M274.49M299.96M
Weighted Avg Shares (Diluted)204.14M224.55M253.63M288.37M299.96M

Pacific Biosciences of California, Inc.

NASDAQ:PACB

Intrinsic Alpha fair value

Locked

Current Price

$1.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.